GLP-1R agonists and uses thereof
US10844049B2 · kind B2 · utility
7Cited by
1References
32Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 15, 2020 |
| Grant date | Nov 24, 2020 |
| Priority date | — |
| Expiry date | May 15, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention described herein provides compounds of Formula (I) and pharmaceutical compositions thereof, for use in, e.g. treating type 2 diabetes mellitus, pre-diabetes, obesity, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and cardiovascular disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.